Fabtech Technologies Earnings Call: Key Takeaways
Fabtech Technologies reported strong FY26 performance with 28.4% revenue growth and an order book of ₹900+ crore, driven by global expansion in turnkey life sciences solutions.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
40 announcements with these filters
Fabtech Technologies reported strong FY26 performance with 28.4% revenue growth and an order book of ₹900+ crore, driven by global expansion in turnkey life sciences solutions.
Fabtech Technologies Limited reported zero deviation or variation in the utilization of ₹230.30 Crore raised through its IPO for the quarter ended March 31, 2026. The statement was reviewed by the Audit Committee and confirmed by monitoring agency CRISIL Ratings Limited, indicating disciplined deployment of public issue proceeds.
Fabtech Technologies Limited's board has approved the incorporation of a new step-down subsidiary in the Sultanate of Oman. The entity will focus on Turnkey Pharma Projects, including HVAC and machinery. While the consideration amount is yet to be finalized, the company will hold a 100% stake via cash subscription at face value.
Fabtech Technologies Limited's Board has recommended a final dividend of ₹0.60 per equity share for the financial year 2025-26. The record date and the date for the General Meeting to approve the dividend will be determined and announced in due course.
Fabtech Technologies Ltd reported revenue from operations of ₹158.5 Cr (+17.5% YoY) and net profit of ₹22.1 Cr (+46.4% YoY) for Q4 FY26.
Fabtech Technologies Limited reported audited consolidated financial results for FY26 and recommended a final dividend of ₹0.60 per share. The company also authorized the opening of a step-down subsidiary in Oman to expand its turnkey pharma project operations. The results show annual consolidated revenue of ₹410.77 Crore and net profit of ₹38.36 Crore.
Fabtech Technologies Limited has scheduled a Board Meeting on April 27, 2026, to approve audited financial results for the year ended March 31, 2026. The board will also consider recommending a dividend. The trading window for designated persons remains closed until 48 hours after the results declaration.
Fabtech Technologies Limited has scheduled a board meeting for April 27, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 31, 2026, and a proposal for a final dividend. The trading window remains closed until 48 hours after the results declaration.
Fabtech Technologies Limited submitted its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The registrar, Bigshare Services, confirmed that all company shares are held in dematerialized form and no rematerialisation requests were received during the quarter.
Fabtech Technologies Limited reported a robust consolidated order book exceeding ₹900 Crore as of March 31, 2026. Despite global logistics and cost challenges, the company secured high-impact projects in the pharmaceutical and animal health segments across Saudi Arabia and Africa, reinforcing its global growth trajectory.